Abstract：The incidence of renal angiomyolipoma, a benign tumor originated from renal parenchyma, is increasing in recent years due to the development of medical imaging and the prevalence of routine physical examination. Progressive growing of the tumor is usually accompanied by deterioration of the renal tissue and sometimes a life threatening hemorrhage may occur. This review summarized the proceedings in diagnosis and treatment of renal angiomyolipoma in recent years based on the progression of cell biology and minimally invasive technique.
[1]Steiner MS, Goldman SM, Fishman EK, et al. The natural history of renal angiomyolipoma. J Urol, 1993, 50:1782-1786. [2]Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol, 1998,15(1):21-40. [3]Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int, 2004, 66(3):924-934. [4]Folpe AL. Neoplasms with perivascular epithelioid cell differentiation (PEComas). In: Fletcher CDM, Unni KK, Epstein J, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. Series: WHO Classification of tumours. IARC Press, Lyon, 2002, 221-222. [5]L'Hostis H, Deminiere C, Ferriere JM, et al. Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol,1999, 3(9):1011-1020. [6]Yan X, Shi L, Chen G,et al. Mesenchymal stem cell-like cells in classic renal angiomyolipoma. Oncol Lett, 2012, 4(3):398-402. [7]Stephen A, Boorjian, Yuri Sheinin, et al. Hormone receptor expression in renal angiomyolipoma:clinicopathologic correlation. Urology, 2008,72(4): 927-932. [8]Mehta V, Venkataraman G, Antic T, et al. Renal angiomyolipoma, fat-poor variant-a clinicopathologic mimicker of malignancy. Virchows Arch. 2013, 463(1):41-46. [9]Kim JK, Kim SH, Jang YJ, et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double echo chemical shift FLASH MR imaging. Radiology, 2006,239(1):174-180. [10]Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology, 1997,205(2): 497-502. [11]Simpfendorfer C, Herts B, Motta-Ramirez GA, et al. Angiomyolipoma with minimal fat on MDCT: can counts of negative-attenuation pixels aid diagnosis? AJR Am J Roentgenol, 2009, 192(2):438-443. [12]Chun-Yi Lin, Hui-Yi Chen, Hueisch-Jy Ding, et al. FDG PET or PET/CT in evaluation of renal angiomyolipoma. Korean J Radiol, 2013,14(2):337-342. [13]Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005, 29(12):1558-1575. [14]Yamakado K, Tanaka N, Nakagawa T, et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture.Radiology, 2002, 225(1): 78-82. [15]Sooriakumaran P, Gibbs P, Coughlin G, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int, 2010, 105(1): 101-106. [16]Rimon U, Duvdevani M, Garniek A, et al. Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin Radiol, 2006, 61(6): 520-526. [17]Karbowniczek M, Yu J, Henske EP. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. Am J Pathol, 2003, 162(2): 491-500. [18]Yamakado K, Tanaka N, Nakagawa T, et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology, 2002, 225(1): 78-82. [19]Chan CK, Yu S, Yip S, et al. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology, 2011, 77(3):642-648. [20]Ramon J, Rimon U, Garniek A, et al. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol, 2009, 55(5):1155 -1161. [21]陈毅,谢春明,杨敏玲,等. 介入治疗肾血管平滑肌脂肪瘤破裂出血的疗效.中国介入影像与治疗学, 2011, 8(1):30-32. [22]Byrd GF, Lawatsch EJ, Mesrobian HG, et al. Laparoscopic cyoablation of renal angiomylipoma. J Urol, 2006,176(4Pt 1):1512-1516. [23]Prevoo W, van den Bosch MA, Horenblas S. Radiofrequency ablation for treatment of sporadic angiomyolipoma.Urology, 2008, 72(1):188-191. [24]Gregory SM, Anderson CJ, Patel U. Radiofrequency ablation of large renal angiomyolipoma: median-term follow-up. Cardiovasc Intervent Radiol, 2013, 36(3):682-689. [25]Hui GC, Tuncali K, Tatli S, et al. Comparison of percutaneous and surgical approaches to renal tumor ablation: meta analysis of effectiveness and complication rates. J Vasc Interv Radiol, 2008, 19(9):1311-1320. [26]Boorjian SA, Frank I, Inman B, et al. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology, 2007,70(6):1064-1068. [27]Xu B, Zhang Q, Jin J. Laparoscopic aspiration for central renal angiomyolipoma: a novel technique based on single-center initial experience. Urology, 2013,81(2):313-318. [28]朱捷, 高江平, 徐阿祥, 等. 无需打结的后腹腔镜保留肾单位肾部分切除术——介绍一种快速简单的腹腔镜缝合术. 临床泌尿外科杂志, 2010,25(5):359-362. [29]马鑫,李宏召,张旭,等. 后腹腔镜肾部分切除术中免打结分层缝合法修补肾脏组织缺损的临床应用研究. 临床泌尿外科杂志,2012,27(2):81-83. [30]http://www.angiotech.com/focus-markets/wound-closure/quill/ [31]徐阿祥, 高江平, 朱捷, 等. 机器人辅助腹腔镜剜除加肾部分切除治疗肾错构瘤6例报告. 临床泌尿外科杂志, 2011,26(12):884-887. [32]Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med, 2008,358(2):140-151. [33]Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet, 2013, 381(9869):817-824.
